nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—Fibrosis—Carmustine—malignant glioma	0.041	0.0562	CcSEcCtD
Timolol—Hyperaemia—Carmustine—malignant glioma	0.0388	0.0532	CcSEcCtD
Timolol—Cerebral ischaemia—Temozolomide—malignant glioma	0.0234	0.0321	CcSEcCtD
Timolol—Visual acuity reduced—Temozolomide—malignant glioma	0.0191	0.0261	CcSEcCtD
Timolol—Respiratory failure—Temozolomide—malignant glioma	0.0115	0.0158	CcSEcCtD
Timolol—Dry eye—Temozolomide—malignant glioma	0.0105	0.0143	CcSEcCtD
Timolol—Abnormal vision—Carmustine—malignant glioma	0.0102	0.014	CcSEcCtD
Timolol—Abnormal vision—Temozolomide—malignant glioma	0.00988	0.0135	CcSEcCtD
Timolol—Eye pain—Carmustine—malignant glioma	0.00943	0.0129	CcSEcCtD
Timolol—Eye pain—Temozolomide—malignant glioma	0.00911	0.0125	CcSEcCtD
Timolol—Amnesia—Carmustine—malignant glioma	0.00906	0.0124	CcSEcCtD
Timolol—Nasal congestion—Temozolomide—malignant glioma	0.00903	0.0124	CcSEcCtD
Timolol—Amnesia—Temozolomide—malignant glioma	0.00875	0.012	CcSEcCtD
Timolol—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00872	0.0119	CcSEcCtD
Timolol—Diplopia—Carmustine—malignant glioma	0.00851	0.0117	CcSEcCtD
Timolol—Diplopia—Temozolomide—malignant glioma	0.00823	0.0113	CcSEcCtD
Timolol—Affect lability—Temozolomide—malignant glioma	0.0081	0.0111	CcSEcCtD
Timolol—Liver function test abnormal—Carmustine—malignant glioma	0.00786	0.0108	CcSEcCtD
Timolol—Mood swings—Temozolomide—malignant glioma	0.00779	0.0107	CcSEcCtD
Timolol—Breast disorder—Temozolomide—malignant glioma	0.00743	0.0102	CcSEcCtD
Timolol—Dysuria—Temozolomide—malignant glioma	0.00665	0.0091	CcSEcCtD
Timolol—Hyperglycaemia—Carmustine—malignant glioma	0.00664	0.00908	CcSEcCtD
Timolol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00661	0.00905	CcSEcCtD
Timolol—Erectile dysfunction—Temozolomide—malignant glioma	0.00655	0.00896	CcSEcCtD
Timolol—Depression—Carmustine—malignant glioma	0.00654	0.00895	CcSEcCtD
Timolol—Weight decreased—Temozolomide—malignant glioma	0.00643	0.00881	CcSEcCtD
Timolol—Hyperglycaemia—Temozolomide—malignant glioma	0.00641	0.00878	CcSEcCtD
Timolol—Depression—Temozolomide—malignant glioma	0.00632	0.00865	CcSEcCtD
Timolol—Sinusitis—Temozolomide—malignant glioma	0.00595	0.00814	CcSEcCtD
Timolol—Hallucination—Carmustine—malignant glioma	0.00586	0.00802	CcSEcCtD
Timolol—Oedema peripheral—Carmustine—malignant glioma	0.0058	0.00794	CcSEcCtD
Timolol—Connective tissue disorder—Carmustine—malignant glioma	0.00579	0.00792	CcSEcCtD
Timolol—Visual impairment—Carmustine—malignant glioma	0.00567	0.00777	CcSEcCtD
Timolol—Hallucination—Temozolomide—malignant glioma	0.00566	0.00775	CcSEcCtD
Timolol—Oedema peripheral—Temozolomide—malignant glioma	0.00561	0.00767	CcSEcCtD
Timolol—Connective tissue disorder—Temozolomide—malignant glioma	0.00559	0.00766	CcSEcCtD
Timolol—Eye disorder—Carmustine—malignant glioma	0.0055	0.00753	CcSEcCtD
Timolol—Visual impairment—Temozolomide—malignant glioma	0.00548	0.00751	CcSEcCtD
Timolol—Eye disorder—Temozolomide—malignant glioma	0.00532	0.00728	CcSEcCtD
Timolol—Tinnitus—Temozolomide—malignant glioma	0.00531	0.00726	CcSEcCtD
Timolol—Cardiac disorder—Temozolomide—malignant glioma	0.00528	0.00723	CcSEcCtD
Timolol—Arrhythmia—Carmustine—malignant glioma	0.00526	0.0072	CcSEcCtD
Timolol—Alopecia—Carmustine—malignant glioma	0.0052	0.00712	CcSEcCtD
Timolol—Angiopathy—Temozolomide—malignant glioma	0.00516	0.00707	CcSEcCtD
Timolol—Mental disorder—Carmustine—malignant glioma	0.00516	0.00706	CcSEcCtD
Timolol—Immune system disorder—Temozolomide—malignant glioma	0.00514	0.00704	CcSEcCtD
Timolol—Mediastinal disorder—Temozolomide—malignant glioma	0.00513	0.00702	CcSEcCtD
Timolol—Erythema—Carmustine—malignant glioma	0.00513	0.00702	CcSEcCtD
Timolol—Malnutrition—Carmustine—malignant glioma	0.00513	0.00702	CcSEcCtD
Timolol—Alopecia—Temozolomide—malignant glioma	0.00503	0.00688	CcSEcCtD
Timolol—Mental disorder—Temozolomide—malignant glioma	0.00499	0.00682	CcSEcCtD
Timolol—Erythema—Temozolomide—malignant glioma	0.00495	0.00678	CcSEcCtD
Timolol—Malnutrition—Temozolomide—malignant glioma	0.00495	0.00678	CcSEcCtD
Timolol—Dysgeusia—Temozolomide—malignant glioma	0.00485	0.00664	CcSEcCtD
Timolol—Vision blurred—Carmustine—malignant glioma	0.00483	0.00661	CcSEcCtD
Timolol—Vision blurred—Temozolomide—malignant glioma	0.00467	0.00639	CcSEcCtD
Timolol—Angioedema—Temozolomide—malignant glioma	0.00453	0.0062	CcSEcCtD
Timolol—Vertigo—Temozolomide—malignant glioma	0.00445	0.00609	CcSEcCtD
Timolol—Hypertension—Carmustine—malignant glioma	0.00443	0.00606	CcSEcCtD
Timolol—Palpitations—Temozolomide—malignant glioma	0.00438	0.00599	CcSEcCtD
Timolol—Chest pain—Carmustine—malignant glioma	0.00436	0.00597	CcSEcCtD
Timolol—Myalgia—Carmustine—malignant glioma	0.00436	0.00597	CcSEcCtD
Timolol—Anxiety—Carmustine—malignant glioma	0.00435	0.00595	CcSEcCtD
Timolol—Cough—Temozolomide—malignant glioma	0.00432	0.00592	CcSEcCtD
Timolol—Hypertension—Temozolomide—malignant glioma	0.00428	0.00585	CcSEcCtD
Timolol—Confusional state—Carmustine—malignant glioma	0.00422	0.00577	CcSEcCtD
Timolol—Arthralgia—Temozolomide—malignant glioma	0.00422	0.00577	CcSEcCtD
Timolol—Myalgia—Temozolomide—malignant glioma	0.00422	0.00577	CcSEcCtD
Timolol—Anxiety—Temozolomide—malignant glioma	0.0042	0.00575	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00419	0.00573	CcSEcCtD
Timolol—Oedema—Carmustine—malignant glioma	0.00418	0.00573	CcSEcCtD
Timolol—Discomfort—Temozolomide—malignant glioma	0.00417	0.0057	CcSEcCtD
Timolol—Infection—Carmustine—malignant glioma	0.00416	0.00569	CcSEcCtD
Timolol—Dry mouth—Temozolomide—malignant glioma	0.00412	0.00565	CcSEcCtD
Timolol—Confusional state—Temozolomide—malignant glioma	0.00408	0.00558	CcSEcCtD
Timolol—Anaphylactic shock—Temozolomide—malignant glioma	0.00404	0.00553	CcSEcCtD
Timolol—Oedema—Temozolomide—malignant glioma	0.00404	0.00553	CcSEcCtD
Timolol—Infection—Temozolomide—malignant glioma	0.00402	0.0055	CcSEcCtD
Timolol—Anorexia—Carmustine—malignant glioma	0.00399	0.00546	CcSEcCtD
Timolol—Nervous system disorder—Temozolomide—malignant glioma	0.00396	0.00543	CcSEcCtD
Timolol—Skin disorder—Temozolomide—malignant glioma	0.00393	0.00538	CcSEcCtD
Timolol—Hypotension—Carmustine—malignant glioma	0.00391	0.00535	CcSEcCtD
Timolol—Hyperhidrosis—Temozolomide—malignant glioma	0.00391	0.00535	CcSEcCtD
Timolol—Anorexia—Temozolomide—malignant glioma	0.00385	0.00528	CcSEcCtD
Timolol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00381	0.00522	CcSEcCtD
Timolol—Insomnia—Carmustine—malignant glioma	0.00378	0.00518	CcSEcCtD
Timolol—Paraesthesia—Carmustine—malignant glioma	0.00376	0.00514	CcSEcCtD
Timolol—Dyspnoea—Carmustine—malignant glioma	0.00373	0.00511	CcSEcCtD
Timolol—Somnolence—Carmustine—malignant glioma	0.00372	0.00509	CcSEcCtD
Timolol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00368	0.00504	CcSEcCtD
Timolol—Insomnia—Temozolomide—malignant glioma	0.00366	0.00501	CcSEcCtD
Timolol—Decreased appetite—Carmustine—malignant glioma	0.00364	0.00498	CcSEcCtD
Timolol—Paraesthesia—Temozolomide—malignant glioma	0.00363	0.00497	CcSEcCtD
Timolol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00361	0.00494	CcSEcCtD
Timolol—Dyspnoea—Temozolomide—malignant glioma	0.0036	0.00493	CcSEcCtD
Timolol—Somnolence—Temozolomide—malignant glioma	0.00359	0.00492	CcSEcCtD
Timolol—Pain—Carmustine—malignant glioma	0.00358	0.0049	CcSEcCtD
Timolol—Dyspepsia—Temozolomide—malignant glioma	0.00356	0.00487	CcSEcCtD
Timolol—Decreased appetite—Temozolomide—malignant glioma	0.00351	0.00481	CcSEcCtD
Timolol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00349	0.00478	CcSEcCtD
Timolol—Fatigue—Temozolomide—malignant glioma	0.00349	0.00477	CcSEcCtD
Timolol—Pain—Temozolomide—malignant glioma	0.00346	0.00473	CcSEcCtD
Timolol—Feeling abnormal—Carmustine—malignant glioma	0.00345	0.00472	CcSEcCtD
Timolol—Gastrointestinal pain—Carmustine—malignant glioma	0.00342	0.00468	CcSEcCtD
Timolol—Feeling abnormal—Temozolomide—malignant glioma	0.00333	0.00456	CcSEcCtD
Timolol—Abdominal pain—Carmustine—malignant glioma	0.00331	0.00453	CcSEcCtD
Timolol—Body temperature increased—Carmustine—malignant glioma	0.00331	0.00453	CcSEcCtD
Timolol—Gastrointestinal pain—Temozolomide—malignant glioma	0.00331	0.00453	CcSEcCtD
Timolol—Urticaria—Temozolomide—malignant glioma	0.00321	0.0044	CcSEcCtD
Timolol—Abdominal pain—Temozolomide—malignant glioma	0.0032	0.00438	CcSEcCtD
Timolol—Body temperature increased—Temozolomide—malignant glioma	0.0032	0.00438	CcSEcCtD
Timolol—Hypersensitivity—Carmustine—malignant glioma	0.00308	0.00422	CcSEcCtD
Timolol—Asthenia—Carmustine—malignant glioma	0.003	0.00411	CcSEcCtD
Timolol—Hypersensitivity—Temozolomide—malignant glioma	0.00298	0.00408	CcSEcCtD
Timolol—Asthenia—Temozolomide—malignant glioma	0.0029	0.00397	CcSEcCtD
Timolol—Diarrhoea—Carmustine—malignant glioma	0.00286	0.00392	CcSEcCtD
Timolol—Pruritus—Temozolomide—malignant glioma	0.00286	0.00392	CcSEcCtD
Timolol—Dizziness—Carmustine—malignant glioma	0.00277	0.00379	CcSEcCtD
Timolol—Diarrhoea—Temozolomide—malignant glioma	0.00277	0.00379	CcSEcCtD
Timolol—Dizziness—Temozolomide—malignant glioma	0.00267	0.00366	CcSEcCtD
Timolol—Vomiting—Carmustine—malignant glioma	0.00266	0.00364	CcSEcCtD
Timolol—Rash—Carmustine—malignant glioma	0.00264	0.00361	CcSEcCtD
Timolol—Dermatitis—Carmustine—malignant glioma	0.00264	0.00361	CcSEcCtD
Timolol—Headache—Carmustine—malignant glioma	0.00262	0.00359	CcSEcCtD
Timolol—Vomiting—Temozolomide—malignant glioma	0.00257	0.00352	CcSEcCtD
Timolol—Rash—Temozolomide—malignant glioma	0.00255	0.00349	CcSEcCtD
Timolol—Dermatitis—Temozolomide—malignant glioma	0.00255	0.00349	CcSEcCtD
Timolol—Headache—Temozolomide—malignant glioma	0.00253	0.00347	CcSEcCtD
Timolol—Nausea—Carmustine—malignant glioma	0.00248	0.0034	CcSEcCtD
Timolol—Nausea—Temozolomide—malignant glioma	0.0024	0.00329	CcSEcCtD
Timolol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	0.000138	0.000511	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KDR—malignant glioma	0.000138	0.00051	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000137	0.000509	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	0.000136	0.000506	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAG1—malignant glioma	0.000136	0.000505	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	0.000136	0.000503	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000135	0.000502	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	0.000134	0.000496	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	0.000133	0.000495	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—F2—malignant glioma	0.000133	0.000494	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000133	0.000493	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—F2—malignant glioma	0.000132	0.000491	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FN1—malignant glioma	0.000132	0.000491	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—IDH1—malignant glioma	0.000132	0.00049	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BAD—malignant glioma	0.000131	0.000485	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	0.000131	0.000485	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—F2—malignant glioma	0.00013	0.000483	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOTCH1—malignant glioma	0.00013	0.000481	CbGpPWpGaD
Timolol—ABCB1—Metabolism—IDH1—malignant glioma	0.000129	0.000478	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000129	0.000478	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	0.000128	0.000476	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000128	0.000474	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SPHK1—malignant glioma	0.000128	0.000474	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	0.000127	0.000472	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CD80—malignant glioma	0.000127	0.000471	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—APC—malignant glioma	0.000127	0.00047	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CG—malignant glioma	0.000127	0.00047	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.000125	0.000466	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGF—malignant glioma	0.000125	0.000465	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.000125	0.000465	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	0.000125	0.000464	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SPHK1—malignant glioma	0.000125	0.000463	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000125	0.000462	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTPN11—malignant glioma	0.000124	0.000462	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	0.000124	0.000461	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000123	0.000457	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.000122	0.000454	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000122	0.000453	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KNG1—malignant glioma	0.000122	0.000451	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.000122	0.000451	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—IDH1—malignant glioma	0.000122	0.000451	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000121	0.000447	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BRAF—malignant glioma	0.000119	0.000442	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000119	0.000441	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000118	0.000438	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000118	0.000436	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000117	0.000436	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	0.000116	0.000432	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT2—malignant glioma	0.000116	0.00043	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	0.000116	0.00043	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—malignant glioma	0.000115	0.000428	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000115	0.000427	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.000114	0.000423	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000114	0.000422	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000113	0.000421	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	0.000112	0.000415	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CD—malignant glioma	0.000111	0.000413	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CA—malignant glioma	0.00011	0.000409	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.000109	0.000406	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—KRAS—malignant glioma	0.000109	0.000405	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP3—malignant glioma	0.000108	0.0004	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000108	0.000399	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000107	0.000399	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	0.000107	0.000396	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGF2—malignant glioma	0.000107	0.000396	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.000105	0.000391	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000105	0.00039	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000104	0.000388	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000104	0.000385	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTK2—malignant glioma	0.000104	0.000385	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	0.000103	0.000383	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HES1—malignant glioma	0.000102	0.000378	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTK2—malignant glioma	0.000101	0.000376	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTT1—malignant glioma	0.000101	0.000376	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	0.000101	0.000376	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	0.000101	0.000375	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—malignant glioma	0.0001	0.000372	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	9.99e-05	0.000371	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MDM2—malignant glioma	9.98e-05	0.00037	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HES1—malignant glioma	9.97e-05	0.00037	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAF1—malignant glioma	9.95e-05	0.000369	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	9.91e-05	0.000368	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—malignant glioma	9.89e-05	0.000367	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	9.87e-05	0.000366	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB2—malignant glioma	9.84e-05	0.000365	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	9.77e-05	0.000363	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	9.76e-05	0.000362	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—malignant glioma	9.71e-05	0.00036	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	9.7e-05	0.00036	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	9.65e-05	0.000358	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.59e-05	0.000356	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	9.54e-05	0.000354	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS1—malignant glioma	9.49e-05	0.000352	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	9.49e-05	0.000352	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.46e-05	0.000351	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SPP1—malignant glioma	9.42e-05	0.000349	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	9.37e-05	0.000348	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—malignant glioma	9.33e-05	0.000346	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—malignant glioma	9.32e-05	0.000346	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS1—malignant glioma	9.26e-05	0.000344	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SPP1—malignant glioma	9.21e-05	0.000342	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	9.17e-05	0.00034	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—malignant glioma	9.01e-05	0.000334	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—malignant glioma	8.96e-05	0.000332	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—malignant glioma	8.93e-05	0.000331	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—malignant glioma	8.93e-05	0.000331	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—malignant glioma	8.92e-05	0.000331	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—BCHE—malignant glioma	8.82e-05	0.000327	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—malignant glioma	8.76e-05	0.000325	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—malignant glioma	8.73e-05	0.000324	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS1—malignant glioma	8.73e-05	0.000324	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC5A5—malignant glioma	8.72e-05	0.000323	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	8.71e-05	0.000323	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	8.67e-05	0.000322	CbGpPWpGaD
Timolol—ABCB1—Metabolism—BCHE—malignant glioma	8.61e-05	0.00032	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	8.54e-05	0.000317	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	8.52e-05	0.000316	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC5A5—malignant glioma	8.51e-05	0.000316	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	8.48e-05	0.000315	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—malignant glioma	8.44e-05	0.000313	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—malignant glioma	8.39e-05	0.000311	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	8.35e-05	0.00031	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CAV1—malignant glioma	8.26e-05	0.000306	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.24e-05	0.000306	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—malignant glioma	8.19e-05	0.000304	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.17e-05	0.000303	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—malignant glioma	8.16e-05	0.000303	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—BCHE—malignant glioma	8.12e-05	0.000301	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CAV1—malignant glioma	8.08e-05	0.0003	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.02e-05	0.000297	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—malignant glioma	7.99e-05	0.000296	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—F2—malignant glioma	7.86e-05	0.000292	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FN1—malignant glioma	7.86e-05	0.000292	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.84e-05	0.000291	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BAD—malignant glioma	7.77e-05	0.000288	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	7.69e-05	0.000285	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FN1—malignant glioma	7.69e-05	0.000285	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—F2—malignant glioma	7.69e-05	0.000285	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BAD—malignant glioma	7.6e-05	0.000282	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—malignant glioma	7.58e-05	0.000281	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CD80—malignant glioma	7.53e-05	0.00028	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	7.52e-05	0.000279	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	7.52e-05	0.000279	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—malignant glioma	7.52e-05	0.000279	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—malignant glioma	7.5e-05	0.000278	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—malignant glioma	7.43e-05	0.000276	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	7.39e-05	0.000274	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CD80—malignant glioma	7.37e-05	0.000273	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—malignant glioma	7.36e-05	0.000273	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	7.36e-05	0.000273	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—malignant glioma	7.27e-05	0.00027	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	7.23e-05	0.000268	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.12e-05	0.000264	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—malignant glioma	7.07e-05	0.000262	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—malignant glioma	7.02e-05	0.00026	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—malignant glioma	6.97e-05	0.000259	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—malignant glioma	6.92e-05	0.000257	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT2—malignant glioma	6.88e-05	0.000255	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—malignant glioma	6.85e-05	0.000254	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	6.85e-05	0.000254	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAT—malignant glioma	6.83e-05	0.000253	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—malignant glioma	6.82e-05	0.000253	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT2—malignant glioma	6.73e-05	0.00025	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	6.7e-05	0.000249	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAT—malignant glioma	6.67e-05	0.000247	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	6.61e-05	0.000245	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	6.55e-05	0.000243	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	6.47e-05	0.00024	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	6.47e-05	0.00024	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—malignant glioma	6.46e-05	0.00024	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOR1—malignant glioma	6.45e-05	0.000239	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—malignant glioma	6.44e-05	0.000239	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	6.41e-05	0.000238	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	6.33e-05	0.000235	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF2—malignant glioma	6.33e-05	0.000235	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOR1—malignant glioma	6.3e-05	0.000234	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAT—malignant glioma	6.28e-05	0.000233	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF2—malignant glioma	6.19e-05	0.00023	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	5.95e-05	0.000221	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOR1—malignant glioma	5.93e-05	0.00022	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—malignant glioma	5.92e-05	0.00022	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—malignant glioma	5.92e-05	0.00022	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAF1—malignant glioma	5.9e-05	0.000219	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	5.84e-05	0.000217	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	5.82e-05	0.000216	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—malignant glioma	5.79e-05	0.000215	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAF1—malignant glioma	5.77e-05	0.000214	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	5.76e-05	0.000214	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—malignant glioma	5.73e-05	0.000212	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	5.71e-05	0.000212	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	5.64e-05	0.000209	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	5.54e-05	0.000205	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	5.42e-05	0.000201	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	5.35e-05	0.000198	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—malignant glioma	5.3e-05	0.000197	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—malignant glioma	5.29e-05	0.000196	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAV1—malignant glioma	5.26e-05	0.000195	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	5.23e-05	0.000194	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—malignant glioma	5.19e-05	0.000192	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—malignant glioma	5.18e-05	0.000192	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAV1—malignant glioma	5.13e-05	0.00019	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.02e-05	0.000186	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—malignant glioma	5.01e-05	0.000186	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—malignant glioma	4.98e-05	0.000185	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—malignant glioma	4.9e-05	0.000182	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—malignant glioma	4.87e-05	0.000181	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	4.86e-05	0.00018	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAV1—malignant glioma	4.84e-05	0.000179	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—malignant glioma	4.84e-05	0.000179	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.79e-05	0.000178	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	4.75e-05	0.000176	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—malignant glioma	4.68e-05	0.000173	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—malignant glioma	4.62e-05	0.000172	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—malignant glioma	4.51e-05	0.000167	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	4.5e-05	0.000167	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—malignant glioma	4.45e-05	0.000165	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.41e-05	0.000163	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	4.4e-05	0.000163	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—malignant glioma	4.36e-05	0.000162	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—malignant glioma	4.25e-05	0.000158	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.21e-05	0.000156	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—malignant glioma	4.14e-05	0.000154	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—malignant glioma	4.11e-05	0.000152	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—malignant glioma	4.05e-05	0.00015	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—malignant glioma	4.05e-05	0.00015	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—malignant glioma	3.96e-05	0.000147	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.87e-05	0.000144	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—malignant glioma	3.82e-05	0.000142	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—malignant glioma	3.74e-05	0.000139	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.67e-05	0.000136	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—malignant glioma	3.64e-05	0.000135	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—malignant glioma	3.58e-05	0.000133	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—malignant glioma	3.55e-05	0.000132	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	3.51e-05	0.00013	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	3.44e-05	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—malignant glioma	3.4e-05	0.000126	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.38e-05	0.000125	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—malignant glioma	3.35e-05	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—malignant glioma	3.32e-05	0.000123	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—malignant glioma	3.17e-05	0.000118	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—malignant glioma	3.1e-05	0.000115	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—malignant glioma	2.92e-05	0.000108	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—malignant glioma	2.87e-05	0.000106	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—malignant glioma	2.81e-05	0.000104	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.24e-05	8.3e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—malignant glioma	2.18e-05	8.1e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.06e-05	7.64e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—malignant glioma	1.83e-05	6.78e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—malignant glioma	1.78e-05	6.62e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—malignant glioma	1.68e-05	6.24e-05	CbGpPWpGaD
